In addition, by correlating SRSF1 IRS with the other above-mentioned clinico-pathological parameters by Pearson’s chi-squared test, we found significant differences between SRSF1 IRS and the patient’s gender (p = 0.580), the tumor anatomic site (p = 0.031), and the histological subtype (p = 0.051) (Table 3, Table 4 and Table 5), while age was not associated with the SRSF1 immunoexpression (OR: 0.99, 95% CI 0.95–1.03, p = 0.84). This evidence concerns the gene SRSF1 and neoplasm.